The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 13, H.C. Wainwright reiterated Intellia Therapeutics (NASDAQ:NTLA) as a Buy but lowered the price target to $25 from $30. The price target cut is in response  to a recent share offering expected to result in significant dilution.

The company announced a $180 million follow-on equity offering of 16.7 million shares at $10.75 a share. The price offering represents an 18.6%  discount to the stock’s closing price following the announcement. While the offering was planned at $150 million, it was upsized to $180 million to generate more gross proceeds.

Amid the price target cut due to dilution concerns, H.C. Wainwright remains bullish with a Buy rating, impressed by Intellia Therapeutics’ top-line results in the Phase 3 lonvo-z trials, with 62% of patients turning out attack-free and therapy-free with no adverse events. The company is planning a regulatory submission for a potential first-half 2027 US launch.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage biotechnology company focused on developing potentially curative treatments using CRISPR/Cas9 gene editing technology. The company aims to permanently modify disease-causing genes in the human body through a single course of treatment.

While we acknowledge the potential of NTLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.